{
    "organizations": [],
    "uuid": "94c03a88c68f5186f30463788229efc09f106566",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/04/30/the-associated-press-neurocrine-1q-earnings-snapshot.html",
    "ord_in_thread": 0,
    "title": "Neurocrine: 1Q Earnings Snapshot",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Monday reported a loss of $41.8 million in its first quarter.\nOn a per-share basis, the San Diego-based company said it had a loss of 47 cents.\nThe results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.\nThe biopharmaceutical company posted revenue of $71.1 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $66 million.\nNeurocrine shares have risen 4.5 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $81.08, a climb of 52 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on NBIX at https://www.zacks.com/ap/NBIX",
    "published": "2018-05-01T00:21:00.000+03:00",
    "crawled": "2018-05-01T00:27:10.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "san",
        "diego",
        "ap",
        "neurocrine",
        "bioscience",
        "nbix",
        "monday",
        "reported",
        "loss",
        "million",
        "first",
        "quarter",
        "basis",
        "san",
        "company",
        "said",
        "loss",
        "cent",
        "result",
        "missed",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "eight",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "biopharmaceutical",
        "company",
        "posted",
        "revenue",
        "million",
        "period",
        "surpassing",
        "street",
        "forecast",
        "five",
        "analyst",
        "surveyed",
        "zacks",
        "expected",
        "million",
        "neurocrine",
        "share",
        "risen",
        "percent",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "monday",
        "share",
        "hit",
        "climb",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "nbix",
        "http"
    ]
}